Elevance Health Financials - Benzinga

Elevance Health Inc

ELVNYSE

Trade with Public

Trade with Public

$396.50

0.410.1%

Últ. Act.: Sep 28, 1:30 AM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

Elevance Health Financials

Elevance Health (ELV) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est

Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..

Benzinga Newsdesk

PRO
Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est

Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..

Benzinga Newsdesk

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings

Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.

Avi Kapoor

Elevance Health's Small Outlook Boost Disappoints, Stock Sinks

Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.

Vandana Singh

Earnings Scheduled For July 15, 2026

Companies Reporting Before The Bell • VCI Global (NASDAQ:VCIG) is estimated to report earnings for its Fiscal Year 2025. • PNC Financial Services Gr (NYSE:PNC) is projected to report quarterly earnings at $4.43 per

Benzinga Insights

PRO
Elevance Health Sees FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est

Elevance Health (NYSE:ELV) FY2026 EPS expected to be more than $20.10 vs $20.26 Est..

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved